Cell proliferation and tumors of the central nervous system part 1: Evaluation of mitotic activity

Journal of Neuropathology and Experimental Neurology

Volumn 61, Issue 6, 2002, Pages 501-509

  Prayson, Richard A ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Brain tumors; Cell proliferation; Mitosis; Mitosis counting

Indexed keywords

ARTICLE; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM TUMOR; HUMAN; HUMAN TISSUE; MICROSCOPY; MITOSIS RATE; OBSERVER VARIATION; PRIORITY JOURNAL; PROGNOSIS; TISSUE FIXATION;

EID: 0036270299     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnen/61.6.501     Document Type: Article

References (79)

1. Current concepts in neuro-oncology: The cell cycle - A review
2. Rules to replicate by
3. S phase of the cell cycle
4. Poor agreement in recognition of abnormal mitoses: Requirement for standardization and robust definitions
5. Mitosis counting in tumors
6. The influence of fixation delay on mitotic activity and flow cytometric cell cycle variables
7. Mitotic activity in the tissues of dead mice, and in tissues kept in physiologic salt solution
8. Changes in mitotic rate and cell cycle fractions caused by delayed fixation
9. Mitotic figures in malignant tumors as affected by time before fixation of tissues
10. Variability of mitotic count dependent on fixation time
11. Mitotic activity and delay in fixation of tumor tissue: The influence of delay in fixation on mitotic activity in human osteogenic sarcoma grown in athymic nude mice
12. Does delay in fixation affect the number of mitotic figures in processed tissue?
13. The time of fixation and the mitotic index
14. Is the grading of breast carcinomas affected by a delay in fixation?
15. The influence of fixatives and other variations in tissue processing on nuclear morphometric features
16. Mitosis counting III
17. Mitosis counts: Reproducibility and significance in grading malignancy
18. Estimating mitotic activity in tumors
19. Mitosis counting II
20. Mitosis counting - A need for reappraisal
21. Expression of mitoses per thousand cells and cell density in breast carcinomas: A proposal
22. Improved methods of estimating mitotic activity in solid tumors
23. Mitotically active leiomyomas of the uterus
24. Can you count on the mitotic index?
25. Clinical application of morphologic and immunocytochemical assessments of cell proliferation
26. Uterine leiomyomas with high content of mast cells
27. Reproducibility of the mitosis count in the histologic diagnosis of smooth muscle tumors of the uterus
28. The effect of progestins on the mitotic activity of uterine fibromas
29. Grading of gliomas
30. Glioblastoma multiforme and anaplastic astrocytoma: Pathologic criteria and prognostic implications
31. Diffuse astrocytomal
32. Anaplastic astrocytoma
33. Glioblastoma
34. Grading astrocytomas. A simple and reproducible method
35. Cellular proliferation in pilocytic and diffuse astrocytomas
36. Intratumoral histologic heterogeneity of gliomas. A quantitative study
37. Regional heterogeneity in the proliferative activity of human gliomas as measured by the Ki-67 labeling index
38. Correlations between cytologic composition and biologic behaviour in the glioblastoma multiforme
39. Biology of glioma: Potential clinical implications of glioma cellular heterogeneity
40. The subpopulations and isolated cell types of freshly resected high grade human gliomas; Their influence on the tumor's evolution in vivo and behaviour and therapy in vitro
41. Immunohistochemical determination of protein kinase C expression and proliferative activity in human brain tumors
42. Cellular and tumoural heterogeneity of EGFR gene amplification in human malignant gliomas
43. Clonal expansion of p53 mutant cells is associated with brain tumor progression
44. Heterogeneity in cell loss and frequency of slow growing colonies of human glioma cell lines. Some effects of radiation
45. Determination of the proliferative potential of human brain tumors using the monoclonal antibody Ki-67
46. Changes in proliferating cell nuclear antigen expression in glioblastoma multiforme cells along a stereotactic biopsy trajectory
47. Oligodendroglioma. Histologic evaluation and prognosis
48. Grading of oligodendrogliomas
49. Clinicopathologic correlations in the oligodendroglioma
50. Oligodendroglioma. A comparison of two grading systems
51. Tumors of the central nervous system
52. Anaplastic oligodendroglioma
53. Oligodendrogliomas: Reproducibility and prognostic value of histologic diagnosis and grading
54. Supratentorial lobar ependymomas. Reports on the grading and survival periods in 80 cases, including 46 recurrences
55. Ependymomas and choroid plexus papillomas
56. Raditherapeutic management of adult intraspinal ependymomas
57. Ependymomas
58. Ependymomas: A clinicopathologic study
59. Clinicopathologic study of 61 patients with ependymoma including MIB-1 immunohistochemistry
60. Histologic prognostic factors in ependymoma
61. Infratentorial ependymomas in childhood: Prognostic factors and treatment
62. The prognostic significance of postoperative residual tumor in ependymoma
63. Correlation of microanatomical localization with postoperative survival in posterior fossa ependymomas
64. Anaplastic ependymoma
65. Astrocytomas of the cerebellum: A comparative clinicopathologic study of pilocytic and diffuse astrocytomas
66. The significance of atypia and histologic malignancy in pilocytic astrocytomas of the cerebellum: A clinicopathologic and flow cytometric study
67. Increased mitotic activity as a negative prognostic indicator in pleomorphic xanthoastrocytoma
68. Pleomorphic xanthoastrocytoma: Case report and analysis of the literature concerning the efficacy of resection and the significance of necrosis
69. Anaplastic pleomorphic xanthoastrocytoma
70. Pleomorphic xanthoastrocytoma. What do we really know about it?
71. Meningiomas
72. Meningioma grading: An analysis of histologic parameters
73. "Malignancy" in meningiomas: A clinicopathologic study of 116 patients, with grading implications
74. Classic, atypical, and anaplastic meningioma: Three histopathological subtypes of clinical relevance
75. The growth rate of intracranial meningiomas and its relation to histology: An analysis of 43 patients
76. Atypical and anaplastic meningiomas: Radiology, surgery, radiotherapy and outcome
77. Atypical and malignant meningiomas: A clinicopathologic review
78. Predicting recurrence of intracranial menigniomas. A multivariate clinicopathologic model - Interim report of the New York University Medical Center Meningioma Porject
79. Prognostic significance of proliferative indices in meningiomas